Paul John Nestel

Q: What Schools Are Affiliated With Paul John Nestel

Paul John Nestel is affiliated with the following schools: Australian National University, Monash University, University of Western Ontario, Flinders University, University of Sydney, University of Melbourne

Paul John Nestel's AcademicInfluence.com Rankings

Paul John Nestel

Medical

#825

World Rank

#1080

Historical Rank

Cardiology

#39

World Rank

#39

Historical Rank

medical Degrees

Paul John Nestel

Philosophy

#3049

World Rank

#5017

Historical Rank

Logic

#923

World Rank

#1501

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Paul John Nestel's Degrees

Doctorate Medicine Stanford University

Why Is Paul John Nestel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul John Nestel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. (1998) (5391)
Suppression by diets rich in fish oil of very low density lipoprotein production in man. (1984) (601)
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. (2012) (532)
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? (2011) (510)
Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. (1997) (464)
Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis (2003) (391)
The hyperlipidemia of pregnancy in normal and complicated pregnancies. (1979) (388)
Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. (1992) (354)
The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. (1986) (331)
Lipoprotein predictors of the severity of coronary artery disease in men and women. (1985) (305)
The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. (1984) (296)
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. (1972) (286)
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials (2018) (281)
Fish oil and cardiovascular disease: lipids and arterial function. (2000) (280)
Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. (1994) (279)
Physical factors influencing postprandial glucose and insulin responses to starch. (1980) (277)
The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. (2002) (271)
Increased lipoprotein-remnant formation in chronic renal failure. (1982) (253)
Severity of coronary atherosclerosis related to lipoprotein concentration. (1978) (247)
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk (2009) (241)
Metabolic syndrome: recent prevalence in East and Southeast Asian populations. (2007) (236)
EFFECTS OF THE PROSTAGLANDINS ON HORMONE-INDUCED MOBILIZATION OF FREE FATTY ACIDS. (1964) (233)
Catabolism of very low density lipoprotein B apoprotein in man. (1978) (225)
Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. (2005) (225)
Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. (1991) (224)
RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS. (1964) (223)
Blood-pressure and catecholamine excretion after mental stress in labile hypertension. (1969) (222)
Effects of N-3 fatty acids on lipid metabolism. (1990) (219)
Diurnal Variation in Glucose Tolerance and in Insulin Secretion in Man (1973) (218)
Effects of prostaglandin E opposing those of catecholamines on blood pressure and on triglyceride breakdown in adipose tissue. (1963) (215)
Isoflavones Reduce Arterial Stiffness: A Placebo-Controlled Study in Men and Postmenopausal Women (2003) (209)
Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. (1995) (207)
Distribution and turnover of cholesterol in humans. (1969) (204)
Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. (1990) (197)
Noradrenaline turnover during under- and over-eating in normal weight subjects. (1982) (196)
Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal (2004) (193)
Rate of starch hydrolysis in vitro as a predictor of metabolic responses to complex carbohydrate in vivo. (1981) (191)
Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. (1997) (184)
n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. (1990) (178)
CALORIGENIC EFFECT OF NOREPINEPHRINE CORRELATED WITH PLASMA FREE FATTY ACID TURNOVER AND OXIDATION. (1964) (176)
Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. (1993) (172)
Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. (1996) (167)
Dynamics of reverse cholesterol transport: protection against atherosclerosis. (2002) (165)
Antioxidant vitamins and low-density-lipoprotein oxidation. (1993) (165)
Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. (1993) (164)
Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. (1990) (161)
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus (2016) (161)
Modifying the fatty acid profile of dairy products through feedlot technology lowers plasma cholesterol of humans consuming the products. (1996) (157)
Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. (1994) (153)
Changes in cholesterol synthesis and excretion when cholesterol intake is increased. (1976) (152)
Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease. (2015) (146)
Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods (2001) (144)
Plasma triglyceride response to carbohydrates, fats and caloric intake. (1970) (144)
METABOLISM OF CONSTITUENT LIPIDS OF DOG CHYLOMICRONS. (1963) (141)
Cholesterol metabolism in human obesity. (1973) (140)
Reduced triglyceride formation from long-chain polyenoic fatty acids in rat hepatocytes. (1985) (134)
Fish oil attenuates the cholesterol induced rise in lipoprotein cholesterol. (1986) (129)
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. (2019) (127)
Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. (1980) (126)
FATE OF PALMITATE AND OF LINOLEATE PERFUSED THROUGH THE ISOLATED RAT LIVER AT HIGH CONCENTRATIONS. (1963) (124)
Plasma cholesteryl ester transfer protein activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet. (1994) (121)
Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL in Hep G2 cells. (1987) (120)
Lowering of plasma cholesterol and enhanced sterol excretion with the consumption of polyunsaturated ruminant fats. (1973) (119)
Antiatherogenic functionality of high density lipoprotein: how much versus how good. (2008) (119)
Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis. (1981) (115)
Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. (1998) (113)
Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease (2013) (113)
PLASMA TRIGLYCERIDE CONCENTRATION AND PLASMA FREE FATTY ACID CHANGES IN RESPONSE TO NOREPINEPHRINE IN MAN. (1964) (112)
Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects (2005) (111)
Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects (2009) (111)
Physical Fitness and Reverse Cholesterol Transport (2004) (111)
Identification of apolipoproteins involved in the interaction of human high density lipoprotein3 with receptors on cultured cells. (1985) (108)
Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males. (1991) (106)
Effects of long-term consumption and single meals of chickpeas on plasma glucose, insulin, and triacylglycerol concentrations. (2004) (102)
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. (2009) (102)
Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals (2011) (99)
Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. (1974) (99)
Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. (1973) (98)
The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. (2011) (97)
The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat (1987) (95)
Leptin in human plasma is derived in part from the brain, and cleared by the kidneys (1998) (92)
Increased sterol excretion with polyunsaturated-fat high-cholesterol diets. (1975) (92)
Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol. (1992) (90)
Disposal of Human Chylomicrons Administered Intravenously in Ischemic Heart Disease and Essential Hyperlipemia (1962) (90)
Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. (2014) (88)
Reduction of blood pressure and plasma triglycerides by omega‐3 fatty acids in treated hypertensives (1994) (88)
Cardiovascular disease risk factors in free-living men: comparison of two prudent diets, one based on lactoovovegetarianism and the other allowing lean meat. (1989) (88)
Plasma free fatty acid and triglyceride turnover in obesity. (1968) (88)
Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects. (1981) (86)
Isoflavones: their effects on cardiovascular risk and functions (2003) (86)
Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. (1999) (84)
Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the rat. (1987) (83)
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention. (2018) (82)
Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome. (1968) (81)
Lipoprotein Lipase in Human Adipose Tissue.∗ (1962) (81)
The effects of dietary fatty acids and cholesterol on the milk lipids of lactating women and the plasma cholesterol of breast-fed infants. (1976) (81)
High dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additional cholesterol lowering Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M400074-JLR200 (2004) (81)
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study (2018) (80)
A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin. (1997) (80)
Metabolism of palmitate and linoleate in intact dogs. (1962) (79)
Simvastatin improves arterial compliance in the lower limb but not in the aorta. (2001) (79)
The vascular activity of some isoflavone metabolites: implications for a cardioprotective role (2001) (77)
Metabolism of Atherogenic Lipoproteins by Smooth Muscle Cells of Different Phenotype in Culture (1985) (77)
The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. (1993) (77)
Polyunsaturated fatty acids (n-3, n-6). (1987) (76)
A low-sodium diet supplemented with fish oil lowers blood pressure in the elderly (1992) (76)
Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias. (1991) (74)
The effect of dietary fat supplements on cholesterol metabolism in ruminants. (1978) (74)
Relationship between sensitivity to dietary fat and dietary cholesterol. (1990) (73)
The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects (2012) (72)
In vivo transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins in man. (1979) (71)
Catecholamine secretion and sympathetic nervous responses to emotion in men with and without angina pectoris (1967) (70)
Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio (1993) (69)
Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults (2013) (69)
Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness. (1973) (68)
Plasma cholesterol-lowering potential of edible-oil blends suitable for commercial use. (1992) (68)
THE EFFECT OF CHLOROPHENOXYISOBUTYRIC ACID AND ETHINYL ESTRADIOL ON CHOLESTEROL TURNOVER. (1965) (68)
Interaction of serum lipoproteins with the intestine. Evidence for specific high density lipoprotein-binding sites on isolated rat intestinal mucosal cells. (1983) (68)
Changes in very low density lipoproteins with cholesterol loading in man. (1982) (67)
Turnover of plasma esterified cholesterol in normocholesterolemic and hypercholesterolemic subjects and its relation to body build. (1967) (67)
Modulation of the hypolipidemic effect of fish oils by dietary fiber in rats: studies with rice and wheat bran. (1990) (66)
Lipid Management Guidelines -2001 (2001) (65)
Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. (1976) (65)
SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD. (1962) (65)
Neuroadrenergic Dysfunction Along the Diabetes Continuum (2012) (65)
Genetic factors affecting HDL levels, structure, metabolism and function (2007) (65)
Effect on plasma lipids of interesterifying a mix of edible oils. (1995) (64)
Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. (2012) (64)
Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. (1985) (64)
Mechanism of alcohol-induced hypertriglyceridemia. (1965) (63)
Diurnal fluctuations in triglyceride, free fatty acids, and insulin during sucrose consumption and insulin infusion in man. (1971) (63)
Sympathetic responsiveness to head-up tilt in essential hypertension. (1973) (63)
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease). (2014) (62)
White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin (2005) (62)
An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. (2007) (61)
393 NEUROADRENERGIC DYSFUNCTION ALONG THE DIABETIC CONTINUUM: A COMPARATIVE STUDY IN OBESE METABOLIC SYNDROME SUBJECTS (2012) (60)
Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects. (1983) (60)
Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man. (1973) (59)
Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver. (1972) (58)
Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study (2013) (57)
Blunted norepinephrine responsiveness to changing energy states in obese subjects. (1985) (57)
The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. (2006) (57)
Obesity: changes in lipid metabolism and the role of insulin. (1976) (57)
Cholesterol turnover in man. (1970) (57)
Altered bile acid metabolism during treatment with phenobarbitone. (1973) (57)
Fibrinolytic activity of the blood in intermittent claudication. (1959) (56)
INFLUENCE OF FREE-FATTY-ACID METABOLISM ON GLUCOSE TOLERANCE. (1964) (56)
Vitamin E improves arterial compliance in middle-aged men and women. (1999) (55)
Effects of Dairy Fats within Different Foods on Plasma Lipids (2008) (55)
Cholesterol metabolism in anorexia nervosa and hypercholesterolemia. (1974) (55)
Oat bran lowers plasma cholesterol levels in mildly hypercholesterolemic men. (1992) (54)
Postprandial Plasma Phospholipids in Men Are Influenced by the Source of Dietary Fat. (2015) (54)
Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome (2009) (54)
Dietary supplementation with orange and carrot juice in cigarette smokers lowers oxidation products in copper-oxidized low-density lipoproteins. (1995) (53)
Dietary Supplementation with Chickpeas for at Least 5 Weeks Results in Small but Significant Reductions in Serum Total and Low-Density Lipoprotein Cholesterols in Adult Women and Men (2007) (52)
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study (2009) (52)
Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2. (1990) (51)
Arrhythmias and late sudden death after myocardial infarction. (1968) (50)
Persistent psychological distress and mortality in patients with stable coronary artery disease (2017) (50)
Effects of ethanol on bile acid and cholesterol metabolism. (1976) (50)
Altered properties of high density lipoprotein subfractions in obese subjects. (1997) (50)
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome. (2008) (48)
Trans fatty acids: are its cardiovascular risks fully appreciated? (2014) (48)
Sucrose-induced changes in VLDL- and LDL-B apoprotein removal rates. (1979) (48)
Precursors of plasma triglyceride fatty acids in obesity. (1973) (48)
Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects. (1997) (47)
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study. (2015) (46)
Changes in plasma triglyceride metabolism during withdrawal of bile. (1976) (46)
Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin. (2008) (45)
Effect of a high fat/cholesterol diet with or without eicosapentaenoic acid on plasma lipids, lipoproteins and lipid transfer protein activity in the marmoset. (1990) (45)
Relationship between the concentration and the rate of esterification of free cholesterol by the plasma esterification system (1967) (45)
Turnover of plasma esterified cholesterol: influence of dietary fat and carbohydrate and relation to plasma lipids and body weight. (1970) (44)
Metabolism of palmitic and linoleic acids in man: differences in turnover and conversion to glycerides. (1971) (44)
Absorption in humans of isoflavones from soy and red clover is similar. (2002) (44)
Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome (2018) (44)
Polyunsaturated ruminant fats and cholesterol metabolism in man. (1974) (43)
Tangier disease. Report of a case and studies of lipid metabolism. (1972) (43)
Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods (2012) (43)
Arterial stiffness is rapidly induced by raising the plasma homocysteine concentration with methionine. (2003) (42)
Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study (2016) (42)
A biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men (2004) (42)
Comparison of binding and degradation of high density lipoprotein by intestinal mucosal cells, fibroblasts and adrenal cortical cells in culture. (1983) (42)
Lack of effect of fish oil supplementation on blood pressure in treated hypertensives. (1990) (42)
Oat beta-glucan lowers total and LDL-cholesterol (2001) (41)
Apoprotein C metabolism in man. (1982) (41)
Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. (1994) (41)
Lipoprotn lipase content and triglyceride fatty acid uptake in adipose tissue of rats of differing body weights. (1969) (41)
Effect of dietary cholesterol in normolipidemic subjects is not modified by nature and amount of dietary fat. (1989) (41)
Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models (2012) (41)
Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. (2012) (40)
Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets. (1982) (40)
Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones (2000) (40)
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia. (2020) (40)
Precursor-product relationship between pools of very low density lipoprotein triglyceride. (1972) (40)
The effect of dietary casein and soy protein on cholesterol and very low density lipoprotein metabolism in the rat. (1984) (39)
Effect of a stearic acid-rich, structured triacylglycerol on plasma lipid concentrations. (1998) (39)
Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome (2008) (38)
Low density and high density lipoprotein kinetics and sterol balance in vegetarians. (1981) (36)
Characteristics of the binding of high-density lipoprotein3 by intact cells and membrane preparations of rat intestinal mucosa. (1984) (36)
Relationship between plasma insulin and erythrocyte fatty acid composition. (1998) (36)
Single session exercise stimulates formation of preβ1-HDL in leg muscle Published, JLR Papers in Press, December 1, 2002. DOI 10.1194/jlr.M200436-JLR200 (2003) (35)
Can eating baked beans lower plasma cholesterol? (1990) (35)
A CONTROLLED TRIAL OF LONG‐TERM TREATMENT WITH ANTICOAGULANTS AFTER MYOCARDIAL INFARCTION IN 412 MALE PATIENTS (1967) (35)
Relationship between FFA flux and TGFA influx in plasma before and during the infusion of insulin. (1967) (35)
Increased catabolism of high density lipoprotein in alcoholic hepatitis. (1980) (35)
Diminished plasma free fatty acid clearance in obese subjects. (1978) (35)
The isoflavone metabolite dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism. (2004) (34)
High-density lipoprotein turnover. (1987) (34)
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome. (2007) (34)
Slower removal of intestinal apolipoprotein B-48 than of apolipoprotein B-100 in severely hypertriglyceridemic subjects. (1983) (34)
Plant sterols and atherosclerosis (2013) (34)
Diet but not aerobic exercise training reduces skeletal muscle TNF-α in overweight humans (2004) (34)
Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus. (2011) (34)
Is fat restriction needed with HMGCoA reductase inhibitor treatment? (1992) (33)
Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia. (1973) (33)
Linoleic acid lowers LDL cholesterol without a proportionate displacement of saturated fatty acid. (1991) (33)
Increased plasma cholesterol esterifying activity during Colestipol resin therapy in man. (1974) (33)
The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase and lipogenesis from glucose in fat tissue of rats. (1968) (32)
Control of the forearm microcirculation: interactions with measures of obesity and noradrenaline kinetics. (1998) (32)
On the mechanism by which an ACAT inhibitor (CL 277,082) influences plasma lipoproteins in the rat. (1990) (32)
Turnover of individual cholesterol esters in human liver and plasma. (1966) (32)
Effect of sodium restriction and fish oil supplementation on BP and thrombotic risk factors in patients treated with ACE inhibitors. (1994) (32)
A note on platelet adhesiveness in ischaemic heart disease (1961) (32)
Impact of westernization on carbohydrate and lipid metabolism in Australian Aborigines (1982) (31)
Post-prandial remnant lipids impair arterial compliance. (2001) (31)
Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women. (1995) (30)
Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism. (1992) (30)
Patterns of Catecholamine Excretion in Urine in Hypertension (1970) (30)
The influence of dietary lipid supplementation on cardiac beta-adrenergic receptor adenylate cyclase activity in the marmoset monkey. (1988) (30)
Delineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDL. (2002) (29)
Gender and diet interactions with simvastatin treatment. (1994) (29)
Elevated HDL Cholesterol is Functionally Ineffective in Cardiac Transplant Recipients: Evidence for Impaired Reverse Cholesterol Transport (2006) (29)
Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein. (2004) (29)
Energy metabolism in free-living, ‘large-eating’ and ‘small-eating’ women: studies using 2H218O (1994) (29)
Plasma free fatty acid transport during prolonged glucose consumption and its relationship to plasma triglyceride fatty acids in man. (1972) (28)
Prevalence of hypertension in Kimberley Aborigines and its relationship to ischaemic heart disease An age‐stratified random survey (1992) (28)
Enhanced capacity of n-3 fatty acid-enriched macrophages to oxidize low density lipoprotein mechanisms and effects of antioxidant vitamins. (1996) (28)
A Comparative Study in Obese Metabolic Syndrome (2012) (28)
Triglyceride clearance during diets rich in carbohydrate or fats. (1973) (27)
NEONATAL PLASMA LIPIDS (1972) (27)
Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects (2012) (27)
Nutritional aspects in the causation and management of the metabolic syndrome. (2004) (27)
The hormonal stimulation of high-density lipoprotein binding, internalization and degradation by cultured rat adrenal cortical cells. (1984) (27)
The production of lipolytic activity in the human forearm in response to heparin. (1961) (26)
Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol. (1974) (26)
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. (2008) (26)
Risk factors for hypertension in Kimberley Aborigines (1992) (25)
METABOLISM OF LINOLEATE AND PALMITATE IN PATIENTS WITH HYPERTRIGLYCERIDEMIA AND HEART DISEASE. (1965) (25)
Greater bile acid excretion with soy bean than with cow milk in infants. (1976) (25)
Effect of Long-chain Triglyceride on Human Insulin Secretion (1972) (25)
Metabolism of human plasma triacylglycerol-rich lipoproteins in rodent macrophages: capacity for interaction at beta-VLDL receptor. (1985) (25)
EFFECTS OF DIETARY SODIUM RESTRICTION AND FISH OIL SUPPLEMENTS ON BLOOD PRESSURE IN THE ELDERLY (1991) (25)
METABOLISM OF CHYLOMICRONS OF DIFFERING TRIGLYCERIDE COMPOSITION. (1964) (25)
Characterization of apolipoprotein A-IV complexes and A-IV isoforms in human lymph and plasma lipoproteins. (1984) (24)
Differences in energy metabolism between normal weight ‘large-eating’ and ‘small-eating’ women (1992) (24)
Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux. (2012) (24)
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. (2006) (24)
Very Low Density Lipoprotein B‐Apoprotein Kinetics in Human Subjects: Relationships between Pool Size, Flux, and Removal Rate (1979) (24)
Effects of MK‐733 on plasma lipid and lipoprotein levels in subjects with hypercholesterolaemia (1987) (24)
Differences in bile acid excretion in subjects with hypercholesterolaemia, hypertriglyceridaemia and overweight. (1974) (24)
A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome. (2014) (24)
Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis. (1982) (23)
Interactions of native and modified human low density lipoproteins with human skin fibroblasts. (1978) (23)
The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome. (2013) (23)
The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia (2014) (23)
Statins and metabolism of high density lipoprotein. (2007) (23)
Changes in cholesterol metabolism in infants in response to dietary cholesterol and fat. (1979) (23)
Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects. (1991) (23)
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. (2007) (23)
Effects of a High-Starch Diet with Low or High Fiber Content on Postabsorptive Glucose Utilization and Glucose Production in Normal Subjects (1984) (22)
Coordinate changes in the low density lipoprotein receptor activity of liver and mononuclear cells in the rabbit. (1993) (22)
Plasma squalene as an index of cholesterol synthesis. (1975) (22)
The effects of hypercholesterolaemia, simvastatin and dietary fat on the low density lipoprotein receptor of unstimulated mononuclear cells. (1993) (21)
Insulin-induced glucose utilization influences triglyceride metabolism. (1983) (21)
Relationship between adipose lipoprotein lipase activity and compounds which affect intracellular lipolysis. (1969) (21)
Changes in cholesterol metabolism with dietary cholesterol in children with familial hypercholesterolaemia. (1979) (21)
Diet and coronary heart disease. The National Heart Foundation of Australia. (1992) (21)
Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects. (2000) (21)
The effect of glucose and insulin in vitro on the uptake of triglyceride and on lipoprotein lipase activity in fat pads from normal, fed rats. (1968) (21)
Identification and characterization of mixed disulphide complexes of E apoprotein in high density lipoprotein of subjects with acute alcoholic hepatitis. (1979) (21)
Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages (1998) (21)
Management of dyslipidaemia in patients with type 2 diabetes in Australian primary care (2007) (21)
Metabolic syndrome: multiple candidate genes, multiple environmental factors--multiple syndromes? (2003) (21)
Carbohydrate-induced hypertriglyceridemia and glucose utilization in ischemic heart disease. (1966) (21)
Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolemia (1990) (20)
HIV disease, metabolic dysfunction and atherosclerosis: A three year prospective study (2019) (20)
High catecholamine essential hypertension: clinical and physiological characteristics. (1973) (20)
Triglyceride turnover in coronary heart disease and the effect of dietary carbohydrate. (1966) (20)
Increased transport of intermediate density lipoprotein (IDL) with cholesterol loading (1983) (19)
A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice. (2007) (19)
The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMP. (1980) (19)
Abnormal apolipoprotein composition in alcoholic hepatitis. (1981) (19)
Evaluation of propranolol ("Inderal") in the treatment of angina pectoris. (1966) (19)
Effect of dietary cholesterol on postprandial lipoproteins in three phenotypic groups. (1996) (19)
Oat B glucan lowers total and LDL-cholesterol (2007) (18)
Changes in plasma lipoprotein constituents during constant infusions of heparin. (1975) (18)
Trans fatty acids in the Australian diet (1994) (18)
Role of soy protein in cholesterol-lowering: how good is it? (2002) (18)
Diet but not aerobic exercise training reduces skeletal muscle TNF-alpha in overweight humans. (2004) (17)
Genetic variation and dietary response. (1997) (17)
A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling. (2009) (17)
Modifications in dietary fat quality are associated with changes in serum lipids of older adults independently of lipid medication. (2010) (17)
Perspective: nonalcoholic fatty liver disease and cardiovascular risk. (2013) (17)
Demonstration of a high density lipoprotein (HDL)‐binding protein in Hep G2 cells using colloidal gold‐HDL conjugates (1988) (16)
Marked increase in high density lipoproteins in mountaineers. (1979) (16)
Metabolism of hepatic and plasma triglycerides in rabbits given ethanol or ethionine. (1966) (16)
Practical Guidance for Food Consumption to Prevent Cardiovascular Disease. (2020) (16)
Diet and coronary heart disease (1992) (16)
Single session exercise stimulates formation of pre beta 1-HDL in leg muscle. (2003) (16)
Comparison of turnover of individual cholesterol esters in subjects with low and high plasma cholesterol concentrations. (1965) (15)
Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model. (2017) (15)
Bile acid and cholesterol excretion with carbohydrate-rich diets. (1973) (15)
Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial. (2005) (15)
Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome. (2015) (14)
Fish oil and oat bran in combination effectively lower plasma cholesterol in the rat. (1992) (14)
Saturated and trans fatty acids and coronary heart disease (1999) (14)
HDL3 degradation by proteases in isolated rat intestinal mucosal cells. (1983) (14)
Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far? (2019) (14)
Specific binding of high density lipoprotein (HDL3) is not related to sterol synthesis in rat intestinal mucosa. (1985) (14)
New lipoprotein profiles and coronary heart disease. Improving precision of risk. (1990) (13)
Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations. (1980) (13)
COMPARISON OF A NEW ANORECTIC AGENT AN 448 WITH FENFLURAMINE IN THE TREATMENT OF REFRACTORY OBESITY (1974) (13)
Volume 41 of Handbook of Experimental Pharmacology, D. Kritchevsky (Ed.), in: Hypolipidemic Agents. Springer-Verlag, Berlin, Heidelberg, New York (1975), 488, 81 figs. (1977) (13)
Effect of blood platelets on heparininduced clearing reaction. (1960) (13)
Isoflavones: effects on cardiovascular risk and functions (2004) (12)
Cholesterol content of the human atrium is related to plasma lipoprotein levels. (1978) (12)
HDL levels in Pacific islanders. (1981) (12)
The distribution of triglyceride in subclasses of very low density plasma lipoproteins. (1970) (12)
Cord blood high density lipoprotein concentration in 1797 births: relationship to family history of coronary disease. (1981) (12)
Trans fatty acids and cardiovascular risk markers: does the source matter? (2009) (12)
Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss (2015) (12)
Cholesterol kinetics and faecal steroid excretion in subjects with primary hyperalphalipoproteinaemia. (1980) (12)
OR-52: Comparison of selective aldosterone blockade versus calcium antagonism on blood pressure, vascular compliance, and microalbuminuria in systolic hypertension in older people (2002) (11)
NEONATAL PLASMA LIPIDS (1973) (11)
Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients. (1976) (11)
DIETARY FAT AND CORONARY HEART DISEASE: A REVIEW (1971) (11)
Comparison of plasma lipids at birth and in second year of life. (1976) (11)
The Isoflavone Metabolite Cis-Tetrahydrodaidzein Inhibits ERK-1 Activation and Proliferation in Human Vascular Smooth Muscle Cells (2004) (11)
Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry. (2020) (11)
Plasma cholesterol esterification in vivo in man. (1974) (11)
Influence of diet on the composition of plasma cholesterol esters in man. (1966) (11)
Nutrition and metabolism: the changing face of the dairy-cardiovascular risk paradox (2012) (10)
Restriction fragment length polymorphism of the apolipoprotein B gene and response to dietary fat and cholesterol. (1995) (10)
Homozygous Familial Hypercholesterolemia Occurring with Apoprotein E3 Deficiency: Report of Two Cases (1984) (10)
DO POLYUNSATURATED FATS PREDISPOSE TO MALIGNANT MELANOMA? (1976) (10)
LDL particle size and LDL and HDL cholesterol changes with dietary fat and cholesterol in healthy subjects. (1998) (10)
POSSIBLE USEFULNESS OF SCREENING FOR HYPERLIPIDAEMIA (1977) (10)
Management of dyslipidaemia - evidence and practical recommendations. (2008) (10)
Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years (1992) (10)
Hepatic lipoprotein receptor activity in rats fed casein and soy protein. (1985) (10)
Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidemia and inflammation (2021) (10)
Disposal of Intravenously Administered Fat in Subjects with Atherosclerosis and in Normal Controls (1961) (10)
The Depletion and Restoration of Post-Heparin Lipolytic Activity in the Human Forearm 1 (1970) (9)
Changes in plasma lipids predict pravastatin efficacy in secondary prevention. (2019) (9)
Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects. (2017) (9)
Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood (2020) (9)
Metabolism of high-density lipoprotein in the hyperlipidemic, diabetic SHR/N-corpulent rat. (1987) (9)
PHENPROCOUMON AND HEPARIN AFTER MYOCARDIAL INFARCTION. A 12-MONTH COMPARISON. (1964) (9)
Lower triglyceride production during carbohydrate-rich diets through acarbose, a glucoside hydrolase inhibitor. (1985) (9)
High Density Lipoprotein Apoprotein Variability in a Biracial Population (1983) (8)
RELATIONSHIP BETWEEN ARTERIAL STIFFNESS AND GLUCOSE METABOLISM IN WOMEN WITH METABOLIC SYNDROME (2006) (8)
Metabolism of apolipoprotein C. (1986) (8)
Comment on Trans fatty acids and coronary heart disease risk (1995) (8)
ALIMENTARY LIPAEMIA AND ISCHAEMIC HEART-DISEASE (1961) (8)
Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome. (2015) (8)
Neck Circumference Is Associated with Muscle Sympathetic Nerve Activity in Overweight and Obese Men but Not Women (2017) (8)
The excretion of free noradrenaline and adrenaline by healthy young subjects and by patients with essential hypertension. (1968) (8)
Differences in substrate metabolism between self-perceived 'large-eating' and 'small-eating' women. (1995) (8)
Smooth Muscle Metabolic Reactivity in Atherogenesis: LDL Metabolism and Response to Serum Mitogens Differ According to Phenotype (1982) (8)
Triglyceride turnover after diets rich in carbohydrate or animal fat. (1965) (7)
A comparative study of micronucleus frequency in peripheral blood lymphocytes of human subjects given dietary cis, trans and saturated fat. (1992) (7)
How good is chocolate? (2001) (7)
The in vitro esterification of cholesterol in human liver mitochondria and microsomes. (1967) (7)
Time to treat cholesterol seriously. (1984) (7)
Cholesterol balance during pregnancy. (1978) (7)
Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with rt'2 (1996) (7)
Lack of effect of acute alcohol ingestion on plasma lipids. (1991) (6)
PLASMA LIPOPROTEIN LIPASE ACTIVITY IN ISCHAEMIC HEART DISEASE. (1964) (6)
Preliminary report on the fourth national nutrition and health survey July - August, 1995 (1997) (6)
CHAPTER 11 – DIETARY LONG CHAIN POLYENOIC FATTY ACIDS: 1. SUPPRESSION OF TRIGLYCERIDE FORMATION IN RAT LIVER;: 2. ATTENUATION IN MAN OF THE EFFECTS OF DIETARY CHOLESTEROL ON LIPOPROTEIN CHOLESTEROL1 (1986) (6)
Dietary Fat and Blood Pressure (2019) (6)
Dietary cholesterol and plasma lipoproteins. (1994) (6)
Antibodies against high-density lipoprotein binding proteins enhance high-density lipoprotein uptake but do not affect cholesterol efflux from rat hepatoma cells. (1997) (6)
Dose-Dependent Effect of Rosuvastatin (2009) (6)
Effect of dietary fat supplementation on the composition and positional distribution of fatty acids in ruminant and porcine glycerides (2006) (5)
Review: fish oil and cardiac function. (1991) (5)
Dietary patterns, dietary nutrients and cardiovascular disease. (2022) (5)
Lipoprotein(a) Removal Still a Mystery (2019) (5)
Fats for the food industry: Implications for cholesterol-lowering (2007) (5)
Cholestyramine and probucol synergism. (1982) (5)
Triglyceride turnover in man. Effects of dietary carbohydrate. (1973) (5)
Atherosclerosis in Fijians and Indians in Fiji, and in Australians. (1966) (5)
Changing dietary approaches to prevent cardiovascular disease (2020) (5)
Metabolic syndrome: the new cardiovascular target. (2004) (5)
Sunday, 26 August 2012 (2012) (5)
Fat and cholesterol (1987) (5)
PLASMA LIPID LEVELS IN SURVIVORS FROM MYOCARDIAL INFARCTION (1964) (5)
Effects of insulin therapy and glycemic control on distribution of HDL alpha and pre-beta subfractions in non insulin-dependent diabetic subjects. (1999) (5)
Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects. (1987) (5)
RELATIONSHIP BETWEEN RESISTANCE TO INSULIN AND BODY WEIGHT (1966) (5)
Lower Triglyceride Production with Carbohydrate-Rich Diets During Treatment with Acarbose (1988) (4)
Serum Lipoproteins in Patients with Intermittent Claudication and Myocardial Infarction (1960) (4)
A TRIAL OF LONG‐TERM TREATMENTS AFTER MYOCARDIAL INFARCTION: COMPARISON OF HEPARIN AND PHENPROCOUMON GIVEN FOR SIX MONTHS (1962) (4)
Dairy Foods: Is Its Cardiovascular Risk Profile Changing? (2022) (4)
Fish oil fatty acids beneficially modulate vascular function. (2001) (3)
Current strategies for atherosclerosis and lowering cholesterol. (1989) (3)
Chapter 5 The regulation of lipoprotein metabolism (1987) (3)
Initial plasma high-density lipoprotein distribution in the rat: effects of age, sex, and fasting. (1985) (3)
Metabolic Studies in Hyperlipidaemia (1974) (3)
The relationship between blood fibrinolytic activity, serum lipoproteins and serum cholesterol in atherosclerotic arterial disease. (1960) (3)
High-sensitivity CRP does not independently predict subsequent events in stable CHD patients in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study (2012) (3)
Preliminary report increased transport of intermediate density lipoprotein (LDL) with cholesterol loading. (1983) (3)
Effect of fish oil fatty acids on LDL size, oxidizability and uptake by macrophages (1994) (3)
Body fat distribution is a determinant of the lipoprotein response to dietary fat and cholesterol (1994) (3)
Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. (1977) (3)
Some clinical and chemical manifestations of alcohol-induced hyperlipaemia. (1967) (3)
Atherothrombosis and Coronary Artery Disease, Second Edition, V. Fuster, E.J. Topol, E.G. Nabel (Eds.). Lippincott Williams & Wilkins (2005), RRP: $220.00 (2006) (3)
Practical Considerations of Changing Dietary Cholesterol and Fat (1977) (3)
Overview: extending the indications for treating hypercholesterolemia. (1986) (3)
Cholesterol distribution and turnover in obesity in man. (1969) (3)
Effects of nutrients on vascular function. (2000) (3)
The effect of maternal malnutrition on the progeny in the rat. Studies in vitro of adipose tissue lipogenesis and lipoprotein lipase activity following fructose feeding. (1973) (3)
Long-chain N-3 fatty acids improve large artery elasticity in humans; DHA and EPA are equivalent (2000) (3)
In vivo exchange of cholesteryl esters from low density lipoproteins to high density lipoproteins. (1980) (3)
Autonomic Nervous System: Metabolic Function (2009) (3)
The effect of maternal malnutrition on the progeny in the rat. Studies in vitro of lipogenesis in liver and in vivo of lipogenesis in liver and adipose tissue following fructose feeding. (1973) (2)
Apoprotein metabolism in human obesity. (1982) (2)
Effect of trans fatty acids on serum lipoprotein levels in man. (1994) (2)
Fermented Dairy Foods and Cardiovascular Risk (2017) (2)
Controlling coronary risk through nutrition. (1995) (2)
OBESITY, DIET AND CORONARY HEART DISEASE: REPLY (1980) (2)
Low-Dose Simvastatin in the Treatment of Mild to Moderate Hypercholesterolaemia (1997) (2)
Managing hyperlipidaemia (1988) (2)
Genetic Variation and Dietary Response (Preliminary Pages) (1997) (2)
Low density lipoprotein peptide metabolism in the nephrotic syndrome. (1970) (2)
New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease. (2022) (2)
Dyslipoproteinemia in North America: The Lipid Research Clinics Program Prevalence Study. (1986) (2)
Dietary factors affecting lipoprotein metabolism. (1985) (2)
Adulthood - prevention: Cardiovascular disease (2002) (2)
Dose-Dependent Effect of Rosuvastatin on Very-Low Density Lipoprotein-Apolipoprotein C-III Kinetics in the Metabolic Syndrome (2008) (2)
The effect of chickpeas on human serum lipids and lipoproteins (2004) (2)
Changes in Lp-PLA2 activity in secondary prevention Ppredict coronary events and treatment effect by Pravastatin in the long-term intervention with Pravastatin in ischaemic disease (LIPID) trial (2011) (2)
Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood. (2020) (2)
Mechanisms of Hyperlipoproteinaemia Derived from Multicompartmental Analysis of Very Low-Density Apolipoprotein B-Kinetics (1977) (2)
Effect of weight loss and exercise on the high-density lipoprotein (HDL) lipidome in individuals with metabolic syndrome (METS) (2015) (2)
Lipoprotein Heterogeneity Workshop (2005) (2)
Hepatic lipogenesis, adipose lipoprotein lipase and triglyceride removal in normotriglyceridemic hexose-fed rats. (1970) (2)
Effect of dietary polyunsaturated pork on plasma lipids and sterol excretion in man (2006) (1)
Dietary management of cardiovascular risk including type 2 diabetes. (2020) (1)
Diet and hyperlipidaemia--current questions and controversies. (1988) (1)
The production of fatty lesions in the pulmonary arteries of rabbits by the intravenous injection of thrombi. (1959) (1)
Plasma lipidomic profiles in two large independent cohorts improve upon conventional risk factors to predict cardiovascular events. (2016) (1)
Future Directions in ω6 and ω3 Fatty Acid Research (1994) (1)
Conference report: Dietary guidelines for a new millennium (2000) (1)
The role of fats in the lifecycle stages. Adulthood--treatment: cholesterol-lowering with plant sterols. (2002) (1)
PRACTOLOL IN THE TREATMENT OF ISCHÆMIC HEART PAIN RESULTS OF A CONTROLLED TRIAL (1972) (1)
Intervention with Pravastatin in Ischemic Disease Study term − Partly Account for the Treatment Effect of Pravastatin : Results From the Long Associated Phospholipase A 2 Activity Predict Coronary Events and − Changes in Lipoprotein Online (2013) (1)
Cellular control of cholesterol metabolism (1978) (1)
DIET AND HEART DISEASE (1971) (1)
Optimising plasma lipids: public intervention versus high risk management. (1992) (1)
Obesity and hypertension (1983) (1)
The lipid hypothesis (1988) (1)
Nutritional evidence still lacks consistency. (2007) (1)
Heparin clearing and inhibition in ischaemic heart disease. (1961) (1)
Lipoprotein Protein Receptors and Their Relation to Atherosclerosis (1980) (1)
Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective (2021) (1)
Atherosclerosis V (1980) (1)
PL04 Nutritional strategies to prevent cardiovascular disease (1998) (1)
1P-0216 Reverse cholesterol transport and physical fitness (2003) (1)
Brain natriuretic peptide: a predictor of cardiovascular outcome in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study (2005) (1)
Relationship between S-T segment depression during exercise and increments in the urinary excretion of 3-methoxy 4-hydroxy mandelic acid in men with coronary heart disease. (1967) (1)
INVESTIGATION OF AMINO ACIDURIA IN ERYTHROBLASTOSIS FŒTALIS AND ITS POSSIBLE RELATIONSHIP TO KERNICTERUS (1957) (1)
SULFINPYRAZONE AFTER MYOCARDIAL INFARCTION (1980) (1)
Metabolic syndrome: the major consequence of obesity. (2003) (1)
The effects of dietary weight loss on indices of noradrenaline turnover: Modulatory influence of hyperinsulinemia (2013) (1)
World Review of Nutrition and Dietetics (2016) (1)
The role of fats in the lifecycle stages. Adulthood--prevention: cardiovascular disease. (2002) (1)
Effects of probucol on lipoprotein protein kinetics. (1982) (1)
The role of antioxidants in preventing coronary heart disease (1995) (1)
Experiments on the hepatorenal syndrome. (1955) (1)
Observations on heparin-induced clearing activity in ischaemic heart disease and the effect of prolonged heparin therapy. (1961) (1)
Practolol in hypertension: reduction in sympathetic nervous and renin responses. (1973) (1)
Nutrition and therapeutics—Editorial overview (1990) (1)
Future directions in omega 6 and omega 3 fatty acid research. (1994) (1)
Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood. (2020) (1)
Vitamin E upregulates the LDL receptor in cultured liver cells (1994) (0)
Metabolism of C-apolipoproteins : kinetics of C-11 , C-llll and CIl 12 , and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects (2002) (0)
A noteon platelet adhesiveness inischaemic heart disease (1961) (0)
Relationship between sensitivity to dietary fat and sensitivity to dietary cholesterol in normal and hypercholesterolemic subjects (1989) (0)
Quantitation of C Apolipoprotein Metabolism in Human Subjects (1980) (0)
Management of common forms of hyperlipidaemia. (1985) (0)
Food and the Heart (2011) (0)
P256 HIGH DENSITY LIPOPROTEIN AND CHOLESTEROL EFFLUX IN PATIENTS WITH TYPE 2 DIABETES (2010) (0)
NHMRC workshop on non-pharmacological methods of lowering blood pressure. Obesity and hypertension. (1983) (0)
A Review of Low-Density Lipoprotein-Lowering Diets in the Age of Anti-Sense Technology (2023) (0)
Dietary fibre (1990) (0)
Mechanism of systemic cholesterol efflux in humans after infusion of reconstituted high density lipoprotein (2012) (0)
Abstract 11937: Cholesteryl Ester Transfer Protein (CETP) and Hepatic Lipase (HL) Gene Polymorphisms Affect HDL-C Concentrations and Particle Size but Not Macrophage Cholesterol Efflux (2011) (0)
Chapter 14. Diet and Hyperlipidemia — Current Questions and Controversies (1989) (0)
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium? (2014) (0)
Apolipoprotein AIV Metabolism in Man (1983) (0)
W16-P-062 Effects of phytosterols on lipoprotein metabolism in subjects with the metabolic syndrome (2005) (0)
Adulthood – prevention (2002) (0)
Hyperlipoproteinaemia and Vascular Disease (1973) (0)
Dietary Factors that Affect High Density Lipoprotein Concentrations (2005) (0)
How good is chocolate ? 1 , 2 (0)
4P-0950 Baseline diet glycemic load and glycemic index are determinants of HDL cholesterol levels in patients with coronary heart disease: results from the LIPID study (2003) (0)
Contents Vol. 50, 2006 (2007) (0)
DOSE-DEPENDENT EFFECT OF ROSUVASTATIN ON PLASMA APOLIPOPROTEIN C-III KINETICS IN MEN WITH THE METABOLIC SYNDROME (2008) (0)
Effect of Clinofibrate on Plasma Lipoproteins and Apoproteins (1984) (0)
Health benefits of chickpea and its use in food - an Australia wide study (2002) (0)
Margarine — facts and myths (1995) (0)
Subject Index Vol. 50, 2006 (2007) (0)
Contribution of fats and fatty acids to performance of the elite athlete. (1993) (0)
Effects of long-term consumption and single meals of chickpeas on plasma glucose , insulin , and triacylglycerol concentrations 1 – 3 (2004) (0)
Plasma Lp(a) concentration shows modest predictive power for coronary heart disease events: results from the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) trial (2012) (0)
504 Hyperalphalipoproteinaemia is associated with increased risk of atherosclerosis in heart transplant patients (2004) (0)
PSYCHOTROPIC DRUGS—ARE THEY JUSTIFIED? (1974) (0)
Delineation of the Role of Pre-1-HDL in Cholesterol Efflux Using Isolated Pre-1-HDL (2002) (0)
4ML13 Nutritional management of the metabolic syndrome and its vascular dysfunctions (2003) (0)
Margarine—facts and myths (1994) (0)
Rat lung expresses a LDL-binding protein which is distinct from the LDL receptor (1994) (0)
Acknowledgement to the 2006 Reviewers (2007) (0)
Plasma lipidomic profiles improve upon conventional risk factors to predict cardiovascular events (2016) (0)
2.P.84 Effect of simvastatin on hepatic cholesterol metabolism and biliary lipids in Australian gallstone patients (1997) (0)
Adulthood — treatment (2002) (0)
Nutrition and coronary atherosclerosis (1986) (0)
1.P.362 Soybean isoflavonoids improve systemic arterial compliance (1997) (0)
The n 3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans 1 – 3 (2002) (0)
Special Section: Nutrition and metabolism. (2009) (0)
Persistent psychological distress and mortality in patients with stable coronary artery disease in the LIPID trial (2015) (0)
Biomarkers, surrogates for nutritional evidence. (2002) (0)
Turnover of Very Low Density Lipoprotein Proteins (1980) (0)
Antioxidants and Cardiovascular Risk (1996) (0)
Very Low Density Lipoprotein B-Apoprotein Kinetics in Human Subjects (2005) (0)
Lipids , Lipoproteins , Cholesteryl Ester Transfer Protein , and Lecithin : Cholesterol Acyltransferase (2004) (0)
Complex phospholipids associate with arterial norepinephrine, non-esterified fatty acids and heart rate, markers of sympathetic nerve system in Metabolic Syndrome subjects independently of insulin resistance (2016) (0)
Managing hyperlipidaemia (1988) (0)
Cystatin C adds prognostic value over conventional predictors of cardiovascular disease outcomes: Results from the long-term intervention with Pravastatin in ischaemic disease (LIPID) trial (2011) (0)
Left atrial reduction: the forgotten (1998) (0)
Lipoprotein(A) Predicts Cardiovascular Events In Statin Outcome Trials: Pooled Analysis Of Seven Randomised Controlled Trials (2019) (0)
CORONARY ARTERY DISEASE Lipoprotein predictors of the severity of coronary artery disease in men and women (2005) (0)
Risk factors for 10-year coronary heart disease mortality in patients with prior acute coronary syndromes: The LIPID cohort (2005) (0)
Decreases in plasma phosphatidylinositol species partially explain the reduction in cardiovascular events after pravastatin therapy in secondary prevention. (2016) (0)
Inhibition of triacylglycerol and apoprotein B secretion and of low density lipoprotein binding in Hep G2 cells by eicosapentaenoic acid (1987) (0)
Dietary cholesterol, plasma lipoproteins and cholesterol metabolism (1995) (0)
Human Nutrition and Metabolism Research Communication (2002) (0)
Improving Precision of Risk (2005) (0)
Differences among Hyperlipoproteinaemic Subjects in the Response of Lipoprotein Lipids to Resin Therapy (1975) (0)
Managing combined hyperlipoproteinemia in a man with the metabolic syndrome (2006) (0)
Complications of Hyperbilirubinemia (1958) (0)
Fish oil fatty acids--the answer to heart disease. (1987) (0)
NHF guidelines on managing lipids : NHF review of new studies confirms importance of managing lipids (1997) (0)
Tu-W28:7 An isoflavone metabolite trans-tetrahydrodaidzein reduces arterial stiffness and arterial pressures in subjects with metabolic syndrome (2006) (0)
Effect of polymorphisms on response to dietary fat and cholesterol (1994) (0)
Workshop: Cholesterol and Triglyceride Metabolism in Man (1974) (0)
Effect of dietary cholesterol on plasma cholesterol concentration. (1987) (0)
Nutritional factors in extracoronary atherosclerosis. (1986) (0)
Measurements of C Apoprotein Kinetics in Man (1983) (0)
Abstract: S1-3 DIETARY FATTY ACIDS INCLUDING TFA AND HEART DISEASE (2009) (0)
Dose-dependent effect of rosuvastatin on very-low density lipoprotein apolipoprotein C-III kinetics in men with the metabolic syndrome (2008) (0)
Drugs that affect lipid metabolism (2011) (0)
Abstract: 988 EFFECTS OF DIETARY FATTY ACIDS AND CHOLESTEROL ON CARDIOVASCULAR RISK & OUTCOMES (2009) (0)
Fish oil and cardiovascular disease : lipids and arterial function 1 , 2 (0)
Functional properties of human apo AI mutants (1986) (0)
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations. (2023) (0)
P1875Changes in plasma lipid species following pravastatin treatment predict cardiovascular outcomes and represent a measure of the relative risk reduction in secondary prevention (2018) (0)
DIET BUT NOT AEROBIC EXERCISE TRAINING REDUCES SKELETAL MUSCLE TNF-ALPHA.: P 157 (2004) (0)
Diet, health and disease in Australia (1987) (0)
1WS04-3 Isoflavones for cardiovascular protection (2003) (0)
Poster abstractEffects of menopause and hormone replacement therapy (HRT) on plasma lipids and LDL oxidation (1994) (0)
Hypertension and ischemic heart disease in Australian aborigines. (1991) (0)
659 – PATHOGENETIC MECHANISMS IN HYPERCHOLESTEROLEMIA (1977) (0)
YI-850 DOSE-DEPENDENT IMPROVEMENT IN HIGH-DENSITY LIPOPROTEIN METABOLISM WITH ROSUVASTATIN IN THE METABOLIC SYNDROME (2007) (0)
Consensus That Industrially Produced TFA are Causally Linked to CHD Risk and Outcomes The Spectrum of TFA Isomers in Ruminant and Industrial Products (2014) (0)
Comparison of fat intake in Australian and New Zealand CHD patients: The lipid (long-term intervention with pravastatin in ischaemic disease) study (2002) (0)
Abstract 15520: Incorporating Novel Biomarkers Significantly Improves Risk Stratification for Coronary Heart Disease Patients: the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Trial (2011) (0)
2.E.1 Fish oil, lipids and coronary disease (1997) (0)
Chapter 5 – Lipoprotein Transport (1967) (0)
Comparison of Serum Lipid Profiles in Coronary A tery Disease (2011) (0)
Evaluation of the Antihypertensive Efficacy of Eplerenone and Amlodipine in Older Patients with Systolic Hypertension (2003) (0)
Delineation of the Role of Pre-&bgr;1-HDL in Cholesterol Efflux Using Isolated Pre-&bgr;1-HDL (2002) (0)
Atherosclerosis VII : proceedings of the Seventh International Symposium on Atherosclerosis and the 7th Scientific Committee of the National Heart Foundation of Australia, Melbourne, 6-10 October 1985 (1986) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul John Nestel?

Paul John Nestel is affiliated with the following schools:

Paul John Nestel's Academic­Influence.com Rankings

Paul John Nestel's Degrees

Why Is Paul John Nestel Influential?

Paul John Nestel's Published Works

Published Works

What Schools Are Affiliated With Paul John Nestel?

Paul John Nestel's AcademicInfluence.com Rankings